10-Q Filing

Xenetic Biosciences, Inc. CIK: 1534525 Q2 2018

Filing Information

Form Type	10-Q
Accession Number	`0001683168-18-002256`
Period End Date	20180630
Filing Date	20180810
Fiscal Year	2018
Fiscal Period	Q2
XBRL Instance	xbio-20180630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 56 Income Statement 40 Cash Flow Statement 48

Balance Sheet 56 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	45.45M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	45.45M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	9.04M	shares	Point-in-time
Cash	`Cash`	$5.53M	USD	Point-in-time
Cash	`Cash`	$3.26M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	9.73M	shares	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalents`	$66.51K	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalents`	$66.51K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	9.40M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	8.72M	shares	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$285.00K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$675.57K	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$4.00M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$5.88M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$27.85K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$16.45K	USD	Point-in-time
Goodwill	`Goodwill`	$3.28M	USD	Point-in-time
Goodwill	`Goodwill`	$3.28M	USD	Point-in-time
Indefinite-lived intangible assets	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$9.24M	USD	Point-in-time
Indefinite-lived intangible assets	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$9.24M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$714.03K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$724.71K	USD	Point-in-time
Total assets	`Assets`	$19.16M	USD	Point-in-time
Total assets	`Assets`	$17.26M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$786.78K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$746.53K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.14M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$796.16K	USD	Point-in-time
Other current liabilities	`DeferredCreditsAndOtherLiabilitiesCurrent`	$21.23K	USD	Point-in-time
Other current liabilities	`DeferredCreditsAndOtherLiabilitiesCurrent`	$11.39K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.55M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.94M	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilitiesNoncurrent`	$2.92M	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilitiesNoncurrent`	$2.92M	USD	Point-in-time
Total liabilities	`Liabilities`	$4.86M	USD	Point-in-time
Total liabilities	`Liabilities`	$4.47M	USD	Point-in-time
Commitments and contingent liabilities (Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingent liabilities (Note 9)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value; 45,454,546 shares authorized as of June 30, 2018 and December 31, 2017; 9,727,774 and 9,041,426 shares issued as of June 30, 2018 and December 31, 2017, respectively; 9,403,889 and 8,717,541 shares outstanding as of June 30, 2018 and December 31, 2017, respectively	`CommonStockValue`	$9.04K	USD	Point-in-time
Common stock, $0.001 par value; 45,454,546 shares authorized as of June 30, 2018 and December 31, 2017; 9,727,774 and 9,041,426 shares issued as of June 30, 2018 and December 31, 2017, respectively; 9,403,889 and 8,717,541 shares outstanding as of June 30, 2018 and December 31, 2017, respectively	`CommonStockValue`	$9.73K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$167.58M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$165.25M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-149.78M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-145.93M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$253.73K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$253.73K	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$5.28M	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$5.28M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$14.30M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$12.78M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$17.26M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$19.16M	USD	Point-in-time

Income Statement 40 line items

Line Item	Tag	Value	Unit	Period
Cost of research and development revenue	`CostOfRevenue`	-	USD	2 Qtrs
Cost of research and development revenue	`CostOfRevenue`	$59.09K	USD	1 Quarter
Cost of research and development revenue	`CostOfRevenue`	$59.09K	USD	2 Qtrs
Cost of research and development revenue	`CostOfRevenue`	-	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.09M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$873.84K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$927.07K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.63M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$3.61M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.07M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.97M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.19M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-2.90M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-3.82M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-5.76M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-1.99M	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$-25.28K	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$-27.13K	USD	2 Qtrs
Other income (expense)	`OtherNonoperatingIncomeExpense`	$-34.63K	USD	2 Qtrs
Other income (expense)	`OtherNonoperatingIncomeExpense`	$-35.53K	USD	1 Quarter
Interest income (expense)	`InterestIncomeExpenseNet`	$9.74K	USD	1 Quarter
Interest income (expense)	`InterestIncomeExpenseNet`	$366.00	USD	2 Qtrs
Interest income (expense)	`InterestIncomeExpenseNet`	$-61.00	USD	1 Quarter
Interest income (expense)	`InterestIncomeExpenseNet`	$9.16K	USD	2 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$-32.59K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$-15.53K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$-25.48K	USD	2 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$-26.77K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-3.85M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-2.03M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.78M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-2.92M	USD	1 Quarter
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-0.44	USD	2 Qtrs
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-0.67	USD	2 Qtrs
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-0.23	USD	1 Quarter
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-0.34	USD	1 Quarter
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	8.61M	shares	2 Qtrs
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	8.71M	shares	1 Quarter
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	8.75M	shares	1 Quarter
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	8.73M	shares	2 Qtrs

Cash Flow Statement 48 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-3.85M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-2.03M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.78M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-2.92M	USD	1 Quarter
Depreciation	`Depreciation`	$11.40K	USD	2 Qtrs
Depreciation	`Depreciation`	$14.02K	USD	2 Qtrs
Depreciation	`Depreciation`	$5.00K	USD	1 Quarter
Depreciation	`Depreciation`	$6.00K	USD	1 Quarter
Share-based payments	`ShareBasedCompensation`	$1.23M	USD	2 Qtrs
Share-based payments	`ShareBasedCompensation`	$753.22K	USD	2 Qtrs
Warrant expense for services	`AdjustmentOfWarrantsGrantedForServices`	$63.73K	USD	2 Qtrs
Warrant expense for services	`AdjustmentOfWarrantsGrantedForServices`	$-95.91K	USD	2 Qtrs
Vendor share-based payments	`VendorSharebasedPayments`	$34.85K	USD	2 Qtrs
Vendor share-based payments	`VendorSharebasedPayments`	$60.28K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$3.00M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	-	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$379.88K	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$185.54K	USD	2 Qtrs
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$59.29K	USD	2 Qtrs
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-389.57K	USD	2 Qtrs
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.71M	USD	2 Qtrs
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.75M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$9.26K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-9.26K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	2 Qtrs
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$1.48M	USD	2 Qtrs
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	-	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.48M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	-	USD	2 Qtrs
Net change in cash and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-2.27M	USD	2 Qtrs
Net change in cash and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-1.72M	USD	2 Qtrs
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.40M	USD	Point-in-time
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.32M	USD	Point-in-time
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.11M	USD	Point-in-time
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.60M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.40M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.32M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.11M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.60M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$1.10K	USD	2 Qtrs
Cash paid for interest	`InterestPaidNet`	$678.00	USD	2 Qtrs
Conversion of Series B preferred stock to common stock	`ConversionOfSeriesBPreferredStockToCommonStock`	$185.00	USD	2 Qtrs
Conversion of Series B preferred stock to common stock	`ConversionOfSeriesBPreferredStockToCommonStock`	$316.00	USD	2 Qtrs
Reclassification of common shares issuable to accounts payable	`ReclassificationOfCommonSharesIssuableToAccountsPayable`	$65.98K	USD	2 Qtrs
Reclassification of common shares issuable to accounts payable	`ReclassificationOfCommonSharesIssuableToAccountsPayable`	-	USD	2 Qtrs
Issuance of common stock for promissory note converted in 2016	`IssuanceOfCommonStockForPromissoryNoteConvertedIn2016`	-	USD	2 Qtrs
Issuance of common stock for promissory note converted in 2016	`IssuanceOfCommonStockForPromissoryNoteConvertedIn2016`	$125.00	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.